美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72865-289-24	72865-289	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL	Icosapent ethyl	CAPSULE	ORAL	20240216	N/A	ANDA	ANDA216811	XLCare Pharmaceuticals, Inc.	ICOSAPENT ETHYL	.5 g/1	240 CAPSULE in 1 BOTTLE (72865-289-24)
72865-290-12	72865-290	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL	Icosapent ethyl	CAPSULE	ORAL	20240216	N/A	ANDA	ANDA216811	XLCare Pharmaceuticals, Inc.	ICOSAPENT ETHYL	1 g/1	120 CAPSULE in 1 BOTTLE (72865-290-12)
31722-298-24	31722-298	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL	Icosapent ethyl	CAPSULE	ORAL	20240216	N/A	ANDA	ANDA216811	Camber Pharmaceuticals, Inc.	ICOSAPENT ETHYL	.5 g/1	240 CAPSULE in 1 BOTTLE (31722-298-24)
31722-299-12	31722-299	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL	Icosapent ethyl	CAPSULE	ORAL	20240216	N/A	ANDA	ANDA216811	Camber Pharmaceuticals, Inc.	ICOSAPENT ETHYL	1 g/1	120 CAPSULE in 1 BOTTLE (31722-299-12)
43602-291-05	43602-291	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL	Icosapent ethyl	CAPSULE	ORAL	20220902	N/A	ANDA	ANDA216811	Ascent Pharmaceuticals, Inc	ICOSAPENT ETHYL	1 g/1	500 CAPSULE in 1 BOTTLE (43602-291-05)
43602-291-30	43602-291	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL	Icosapent ethyl	CAPSULE	ORAL	20220902	N/A	ANDA	ANDA216811	Ascent Pharmaceuticals, Inc	ICOSAPENT ETHYL	1 g/1	30 CAPSULE in 1 BOTTLE (43602-291-30)
43602-547-05	43602-547	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL	Icosapent ethyl	CAPSULE	ORAL	20220902	N/A	ANDA	ANDA216811	Ascent Pharmaceuticals, Inc	ICOSAPENT ETHYL	.5 g/1	500 CAPSULE in 1 BOTTLE (43602-547-05)
43602-547-30	43602-547	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL	Icosapent ethyl	CAPSULE	ORAL	20220902	N/A	ANDA	ANDA216811	Ascent Pharmaceuticals, Inc	ICOSAPENT ETHYL	.5 g/1	30 CAPSULE in 1 BOTTLE (43602-547-30)